SuperworthTranslational Development Acquisition shares outstanding TDAC
Diluted shares outstanding, averaged over each quarter, from 2024.
- Latest quarter, to Jun 30, 2026
- 4.7M
- On a year earlier
- +0.0%
- more shares
Translational Development Acquisition had 4.7M diluted shares outstanding on average in Q2 FY26, the quarter to Jun 30, 2026.
That is about the same as a year earlier.
Shares outstanding over time
Quarter by quarter
| Quarter | Ended | Shares outstanding | On a year earlier |
|---|---|---|---|
| Q2 FY26 | 4.7M | +0% | |
| Q1 FY26 | 4.7M | +0% | |
| Q3 FY25 | 4.7M | +15% | |
| Q2 FY25 | 4.7M | +15% | |
| Q1 FY25 | 4.7M | +15% | |
| Q3 FY24 | 4M | n/a | |
| Q2 FY24 | 4M | n/a | |
| Q1 FY24 | 4M | n/a |
What the shares outstanding tells you
Diluted shares outstanding, averaged over the period. Fewer shares means each one owns more of the company.
A falling count usually means buybacks. A rising one means stock pay, acquisitions paid in shares or new shares sold.
More on Translational Development Acquisition
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.